Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

McGill University patent describes TC-PTP inhibitors

Sep. 21, 2015

Bristol-Myers Squibb reports HIV integrase inhibitor macrocycles

Sep. 17, 2015

Gilead patent discloses compounds for the treatment of HIV

Sep. 14, 2015

Bristol-Myers Squibb introduces new HIV integrase inhibitors

Sep. 8, 2015

Bristol-Myers Squibb introduces HIV integrase inhibitors

Sep. 7, 2015

Bristol-Myers Squibb presents macrocyclic HIV integrase inhibitors

Sep. 4, 2015

Bristol-Myers Squibb discloses anti-HIV macrocycles

Sep. 3, 2015

Bristol-Myers Squibb reports HIV integrase inhibitors

Sep. 2, 2015

Bristol-Myers Squibb patents HIV integrase inhibitors

Sep. 1, 2015

Bristol-Myers Squibb discloses HIV integrase inhibitors

Aug. 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.